Zura Bio
Verender Badial is the Chief Financial Officer at Zura Bio Limited. They have extensive experience in finance and investments, having previously held positions such as Director at Cryfield Investments Ltd and CFO at JATT Acquisition Corp. Prior to these roles, they served as CFO at MACKENZIE (SOUTH WEST) HOMES LIMITED and held various executive positions at companies such as Societe Generale and RBS. Verender holds a Bachelor's Degree from The London School of Economics and Political Science and also studied at the University of Warwick - Warwick Business School.
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.